Rockefeller University
Clinical trials sponsored by Rockefeller University, explained in plain language.
-
New antibody shot aimed at taming hepatitis b
Disease control Recruiting nowThis study tests a single dose of a new antibody (HepB mAb19) in 37 adults with chronic hepatitis B who are already on standard antiviral pills. The main goal is to see if the antibody is safe and how long it stays in the body. It is an early-phase trial, so it focuses on safety …
Phase: PHASE1 • Sponsor: Rockefeller University • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Aspirin not working for some Moms-to-Be? scientists investigate
Knowledge-focused Recruiting nowThis study looks at why low-dose aspirin sometimes fails to prevent preeclampsia, a serious pregnancy complication. Researchers will study genetic and platelet factors in 130 women who had preeclampsia before and took aspirin in a later pregnancy. The goal is to understand why so…
Phase: EARLY_PHASE1 • Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:56 UTC
-
Scientists dig into genetic roots of rare bleeding disorders
Knowledge-focused Recruiting nowThis study looks at how blood cells interact and what goes wrong in inherited bleeding disorders like Glanzmann thrombasthenia. Researchers will analyze blood samples from up to 60 healthy volunteers and patients to find genetic defects. The goal is to better understand these con…
Sponsor: Rockefeller University • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC